These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1767154

  • 21. Metabolism and toxicity of aluminum in renal failure.
    Alfrey AC, Hegg A, Craswell P.
    Am J Clin Nutr; 1980 Jul; 33(7):1509-16. PubMed ID: 7395774
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ, Cowie JF, Robson JS.
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract] [Full Text] [Related]

  • 25. Aluminum: a pediatric overview.
    Gruskin AB.
    Adv Pediatr; 1988 Feb; 35():281-330. PubMed ID: 3055861
    [No Abstract] [Full Text] [Related]

  • 26. [Toxic effect of aluminum in chronic renal failure].
    Głuszek J.
    Pol Tyg Lek; 1987 Nov 30; 42(48):1499-502. PubMed ID: 3451199
    [No Abstract] [Full Text] [Related]

  • 27. Aluminum toxicity in dialysis patients.
    Van de Vyver FL, Silva FJ, D'Haese PC, Verbueken AH, De Broe ME.
    Contrib Nephrol; 1987 Nov 30; 55():198-220. PubMed ID: 3549151
    [No Abstract] [Full Text] [Related]

  • 28. Aluminum neurotoxicity: a reevaluation.
    Murray JC, Tanner CM, Sprague SM.
    Clin Neuropharmacol; 1991 Apr 30; 14(2):179-85. PubMed ID: 2015614
    [No Abstract] [Full Text] [Related]

  • 29. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM, Corwin HL, Wilson RS, Mayor GH, Tanner CM.
    Arch Intern Med; 1986 Oct 30; 146(10):2063-4. PubMed ID: 3767553
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Dialysis bone disease associated with other factors].
    Nakazawa R.
    Nihon Rinsho; 1992 Jan 30; 50 Suppl():789-95. PubMed ID: 1578768
    [No Abstract] [Full Text] [Related]

  • 34. [Not Available].
    Moreira AC.
    Krankenpfl Soins Infirm; 2016 Jan 30; 109(12):64-65. PubMed ID: 30549642
    [No Abstract] [Full Text] [Related]

  • 35. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F, Giachino G, Bossi P, Gilli G, Corrao G, Scursatone E, Jeantet A, Bossi R, Coppo R, Piccoli G, Vercellone A.
    Minerva Nefrol; 1980 Jan 30; 27(4):635-44. PubMed ID: 7254691
    [No Abstract] [Full Text] [Related]

  • 36. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB, Foley J, Nelson P, Goodman WG.
    N Engl J Med; 1991 Feb 21; 324(8):527-31. PubMed ID: 1992306
    [Abstract] [Full Text] [Related]

  • 37. Dialysis encephalopathy syndrome.
    Alfrey AC.
    Annu Rev Med; 1978 Feb 21; 29():93-8. PubMed ID: 348053
    [Abstract] [Full Text] [Related]

  • 38. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity.
    Bugiani O, Brancaccio D, Ghetti B.
    Clin Nephrol; 1985 Feb 21; 24 Suppl 1():S20-5. PubMed ID: 3915956
    [Abstract] [Full Text] [Related]

  • 39. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC, LeGendre GR, Kaehny WD.
    N Engl J Med; 1976 Jan 22; 294(4):184-8. PubMed ID: 1244532
    [Abstract] [Full Text] [Related]

  • 40. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL, Leu ML.
    Nephrol Dial Transplant; 1996 Sep 22; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.